Literature DB >> 19116355

Evaluation of a highly sensitive qualitative human immunodeficiency virus type 1 (HIV-1) RNA assay for detection of HIV-1 suppression.

C Thomas Nugent1, Vladislav Nodelman, Cristina Giachetti, Douglas D Richman, David J Looney.   

Abstract

By using a mathematical model, the APTIMA human immunodeficiency virus type 1 (HIV-1) RNA qualitative assay was evaluated as a semiquantitative assay to distinguish HIV-1 patient samples needing quantitation from samples in which the virus was suppressed with antiretroviral therapy.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19116355      PMCID： PMC2650919          DOI： 10.1128/JCM.01464-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Prevalence and predictive value of intermittent viremia with combination hiv therapy.

Authors:  D V Havlir; R Bassett; D Levitan; P Gilbert; P Tebas; A C Collier; M S Hirsch; C Ignacio; J Condra; H F Günthard; D D Richman; J K Wong
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

2.  Comparison of the sensitivities and viral load values of the AMPLICOR HIV-1 MONITOR version 1.0 and 1.5 tests.

Authors:  Angela M Caliendo; Jessica Ingersoll; Alicia M Green; Frederick S Nolte; Kirk A Easley
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

3.  Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.

Authors:  W A O'Brien; P M Hartigan; E S Daar; M S Simberkoff; J D Hamilton
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

4.  Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.

Authors:  Rick Galli; Linda Merrick; Michel Friesenhahn; Rainer Ziermann
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

5.  Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.

Authors:  Janet Vargo; Katie Smith; Caroline Knott; Songbai Wang; Chyang Fang; Sherrol McDonough; Cristina Giachetti; Sally Caglioti; Richard Gammon; Denise Gilbert; J Brooks Jackson; William Richards; Susan Stramer; Larry Mimms
Journal:  Transfusion       Date:  2002-07       Impact factor: 3.157

6.  Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification.

Authors:  Peter A Sklar; Douglas J Ward; Rose K Baker; Kathleen C Wood; Zarina Gafoor; Carlos F Alzola; Anne C Moorman; Scott D Holmberg
Journal:  AIDS       Date:  2002-10-18       Impact factor: 4.177

7.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

8.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

9.  Antiretroviral resistance during successful therapy of HIV type 1 infection.

Authors:  J Martinez-Picado; M P DePasquale; N Kartsonis; G J Hanna; J Wong; D Finzi; E Rosenberg; H F Gunthard; L Sutton; A Savara; C J Petropoulos; N Hellmann; B D Walker; D D Richman; R Siliciano; R T D'Aquila
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

10.  Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure.

Authors:  José A Mira; Juan Macías; Carmen Nogales; Javier Fernández-Rivera; José A García-García; Antonio Ramos; Juan A Pineda
Journal:  Antivir Ther       Date:  2002-12
View more
  2 in total

1.  Ultra-high-throughput, automated nucleic acid detection of human immunodeficiency virus (HIV) for infant infection diagnosis using the Gen-Probe Aptima HIV-1 screening assay.

Authors:  Wendy S Stevens; Lara Noble; Leigh Berrie; Somaya Sarang; Lesley E Scott
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948

2.  Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay.

Authors:  Mark M Manak; Leigh Anne Eller; Jennifer Malia; Linda L Jagodzinski; Rapee Trichavaroj; Joseph Oundo; Cornelia Lueer; Fatim Cham; Mark de Souza; Nelson L Michael; Merlin L Robb; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2017-04-19       Impact factor: 5.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.